AngioDynamics Investor Relations Material

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for use by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings in the United States and internationally. The company operates through four segments: Vascular Access, Peripheral Vascular, Oncology/Surgery, and Venous Therapies. The Peripheral Vascular segment primarily offers radiofrequency ablation systems to ablate or destroy undesired tissue; angiographic products to access the vasculature; thrombolytic products to treat clots; embolization products to block blood flow to a tumor; vena cava filters to trap clot before it can travel to the lungs; dialysis catheters used in hemodialysis procedures; and a range of products used in minimally-invasive, image-guided procedures.